We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.4%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.6B
AUM Growth
+$2.24B
(+5.5%)
Cap. Flow
-$670M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$204M |
| 2 |
JPMorgan Chase
JPM
|
+$72.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$67.5M |
| 4 |
Evergy
EVRG
|
+$66.6M |
| 5 |
NVIDIA
NVDA
|
+$58.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$370M |
| 2 |
United Parcel Service
UPS
|
+$364M |
| 3 |
Dominion Energy
D
|
+$172M |
| 4 |
Moderna
MRNA
|
+$125M |
| 5 |
Teladoc Health
TDOC
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Technology | 20.08% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 9.65% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
976
DELISTED
Amicus Therapeutics
FOLD
| $2.06M | ﹤0.01% |
145,765
+907
| +0.6% | +$13.2K |
|
|
HBI
977
DELISTED
Hanesbrands
HBI
| $2.05M | ﹤0.01% |
129,920
+10,513
| +9% | +$154K |
|
978
Adaptive Biotechnologies
ADPT
$4.42B
| $2.04M | ﹤0.01% |
42,000
| – | – |
|
979
CSX Corp
CSX
$88.7B
| $2.04M | ﹤0.01% |
78,819
-26,124
| -25% | -$644K |
|
|
VMRK
980
Vivmark Residential
VMRK
$48.7B
| $2.04M | ﹤0.01% |
39,749
-3,137
| -7% | -$174K |
|
981
Sonic Automotive
SAH
$2.3B
| $2.04M | ﹤0.01% |
50,830
+50,366
| +10,855% | +$2.04M |
|
982
Kennametal
KMT
$2.27B
| $2.02M | ﹤0.01% |
69,799
-45,852
| -40% | -$1.33M |
|
|
NUVA
983
DELISTED
NuVasive, Inc.
NUVA
| $2.02M | ﹤0.01% |
41,563
-19,018
| -31% | -$1.02M |
|
984
AAR Corp
AIR
$4.72B
| $2.01M | ﹤0.01% |
107,019
-186,710
| -64% | -$3.56M |
|
985
Arcus Biosciences
RCUS
$3.14B
| $2.01M | ﹤0.01% |
117,285
+65,060
| +125% | +$1.45M |
|
986
Dynatrace
DT
$16B
| $2M | ﹤0.01% |
48,839
-318,773
| -87% | -$13.1M |
|
987
Chemed
CHE
$6.66B
| $2M | ﹤0.01% |
4,169
-421
| -9% | -$206K |
|
988
TD Synnex
SNX
$20.8B
| $2M | ﹤0.01% |
28,574
-111,132
| -80% | -$6.99M |
|
989
Helen of Troy
HELE
$634M
| $1.99M | ﹤0.01% |
10,275
+1,983
| +24% | +$394K |
|
|
ZYXI
990
DELISTED
Zynex
ZYXI
| $1.98M | ﹤0.01% |
124,461
-230,785
| -65% | -$3.9M |
|
|
ZNGA
991
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.97M | ﹤0.01% |
215,848
+76,598
| +55% | +$713K |
|
992
Sunrun
RUN
$1.99B
| $1.97M | ﹤0.01% |
+25,518
| New | +$1.2M |
|
|
TALK
993
DELISTED
Talkspace
TALK
| $1.97M | ﹤0.01% |
+200,000
| New | +$1.97M |
|
994
United Therapeutics
UTHR
$21.4B
| $1.97M | ﹤0.01% |
19,454
-190
| -1% | -$20.8K |
|
995
Paylocity
PCTY
$7.82B
| $1.96M | ﹤0.01% |
12,171
+2,979
| +32% | +$419K |
|
996
Mistras Group
MG
$617M
| $1.96M | ﹤0.01% |
501,466
+631
| +0.1% | +$2.54K |
|
997
Toro Company
TTC
$8.74B
| $1.95M | ﹤0.01% |
23,238
-2,411
| -9% | -$180K |
|
|
DRNA
998
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.95M | ﹤0.01% |
108,260
-10,136
| -9% | -$210K |
|
999
Essential Utilities
WTRG
$11.7B
| $1.94M | ﹤0.01% |
48,298
-5,404
| -10% | -$232K |
|
1000
Sempra
SRE
$53.4B
| $1.94M | ﹤0.01% |
32,814
-1,360
| -4% | -$83.7K |
|
Similar funds
Federated Hermes's Q3 2020 Portfolio in Review
As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
- Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
- Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
- Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
- Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
- Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
- Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.
Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.